Cingulate Inc.

CING

Cingulate Inc.

CING

Insider Sentiment (TTM):

Last Purchase:2026-02-13Last Sale:2024-08-15Shares Purchased (TTM):130,350Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,127,550Shares Outstanding:9,777,786Institutional Ownership Pct.:11.53%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	28	26	11	6	9	10	12	10	0	1	0	2
Receivables Net Current	-	-	-	-	-	-	-	0	2	-	-	-
Other Receivables	-	-	-	0	0	0	-	-	-	-	-	-
Other Assets Miscellaneous Current	-	-	0	-	-	-	0	-	-	0	0	0
Other Receivables Net Current	0	0	-	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	2	1	1	1	1	0	1	1	2	1	1
Assets Current	30	28	12	7	10	11	13	11	3	3	1	3
Property Plant And Equipment Net	2	2	2	2	2	2	2	2	2	2	3	3
Operating Lease Right Of Use Asset	1	1	1	1	1	0	0	0	0	0	0	0
Assets	33	31	15	11	13	12	15	14	5	5	3	6
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	3	2	1	1	1	1	1	1	1	5	2
Accrued Liabilities Current	1	2	2	2	1	1	1	0	0	1	2	1
Notes Payable Current	5	6	6	3	5	4	3	-	-	-	3	3
Finance Lease Liability Current	-	-	-	-	-	-	0	0	0	0	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	9	11	10	6	7	6	5	2	2	2	10	6
Liabilities Noncurrent
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Long Term Notes Payable	-	-	1	-	-	1	2	-	-	-	-	-
Operating Lease Liability Noncurrent	1	1	1	1	1	-	-	-	-	0	0	0
Liabilities Noncurrent	1	1	2	1	1	1	2	-	-	0	0	0
Liabilities	10	12	13	7	8	7	7	2	2	2	10	6
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	171	161	135	130	123	118	117	114	102	99	86	86
Retained Earnings Accumulated Deficit	-148	-142	-132	-126	-117	-112	-110	-102	-99	-96	-93	-86
Stockholders Equity	23	19	3	3	6	6	7	12	3	3	-7	-0
Liabilities And Stockholders Equity	33	31	15	11	13	12	15	14	5	5	3	6
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	240	240	240	240	240	240	240	240	-	240	240	240
Common Stock Shares Issued	14	12	7	6	5	4	3	3	1	0	0	1
Shares Outstanding	14	12	7	6	5	4	3	3	1	0	0	1
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	-	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	-	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	-	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	-	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.39%	22.55%	8.43%	-	-	-	-	-	-	-	-	-
2025	-4.16%	-0.98%	34.47%	5.05%	9.31%	-0.80%	19.82%	31.53%	72.37%	-28.36%	-34.45%	-44.09%
2024	-21.06%	-63.96%	-60.25%	163.11%	113.78%	71.11%	26.74%	38.95%	47.67%	-2.53%	-12.18%	-3.45%
2023	-	-	-	4.71%	12.14%	-24.28%	-43.06%	2.10%	-78.55%	-19.27%	-27.61%	-46.79%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.50	2.55	1.16	1.26	1.52	1.87	2.55	7.35	1.23	1.21	0.06	0.51
Quick Ratio	3.30	2.37	1.06	1.04	1.32	1.70	2.46	6.51	0.98	0.50	0.01	0.35
Working Capital	21.58M	16.95M	1.70M	1.55M	3.49M	4.89M	7.69M	9.80M	472.84K	481.59K	-9.65M	-2.83M
Leverage & Debt
Debt to Equity	0.41	0.64	5.01	2.03	1.44	1.10	0.99	0.13	0.66	0.71	-1.51	-61.94
Interest Coverage TTM	-36.75	-35.75	-84.69	-87.34	-75.81	-169.70	-	-	-	-	-	-
Debt Ratio	0.29	0.39	0.83	0.67	0.59	0.52	0.50	0.11	0.40	0.41	2.97	1.02
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Receivables Turnover TTM	-	-	-	-	-	-	-	0.00	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-2.18	-2.85	-4.44	-4.13	-4.38	-4.78	-10.86	-9.76	-32.57	-54.60	-311.99	-257.47
Free Cash Flow Per Share TTM	-1.41	-2.02	-3.44	-2.45	-2.98	-4.04	-12.42	-9.86	-30.16	-49.68	-202.28	-204.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	49.88%	60.03%	35.57%	30.08%	0.62%	-22.50%	-29.64%	-18.69%	-0.82%	34.93%	33.14%	62.23%
EPS Growth (1Y)	-50.11%	-40.31%	-59.11%	-57.70%	-86.56%	-91.24%	-96.52%	-96.21%	64.79%	-84.58%	-11.44%	1,755.63%
Valuation Metrics
P/E TTM	-2.50	-2.18	-0.98	-0.95	-0.93	-0.90	-0.45	-0.52	-0.12	-0.24	-0.29	-0.66
P/B TTM	3.07	3.22	8.74	6.13	3.24	2.64	1.01	0.74	0.73	1.69	-1.01	-145.48
Market Cap	72.13M	60.72M	21.94M	21.29M	17.87M	15.68M	7.52M	8.90M	2.25M	5.44M	6.92M	14.01M
Enterprise Value	48.79M	40.97M	18.43M	18.36M	14.10M	11.21M	274.34K	-1.13M	1.88M	4.34M	9.89M	15.05M
Calculated Values
Free Cash Flow TTM	-18.58M	-19.77M	-17.41M	-13.32M	-13.10M	-14.73M	-18.94M	-17.42M	-17.68M	-20.47M	-15.26M	-16.86M
Net Debt	-23.34M	-19.75M	-3.51M	-2.93M	-3.77M	-4.47M	-7.24M	-10.03M	-367.83K	-1.10M	2.97M	1.04M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-13Purchase

Owner: Hargroves, Thomas Jeffrey

Title: -

Shares: 97,276

Price/Share: $5.04

Value: $490,271.04

Shares Owned: 97,468

Relationship: Director

Ownership: Indirect

2026-02-06Purchase

Owner: Brams, Matthew

Title: EVP and Chief Medical Officer

Shares: 1,946

Price/Share: $5.04

Value: $9,807.84

Shares Owned: 4,656

Relationship: Officer

Ownership: Direct

2026-02-06Purchase

Owner: Werth, Peter J.

Title: -

Shares: 19,455

Price/Share: $5.04

Value: $98,053.20

Shares Owned: 117,449

Relationship: Director

Ownership: Indirect

2026-02-06Purchase

Owner: Schaffer, Shane J.

Title: Chief Executive Officer

Shares: 6,809

Price/Share: $5.04

Value: $34,317.36

Shares Owned: 10,175

Relationship: Director,Officer

Ownership: Indirect

2026-02-06Purchase

Owner: Callahan, Jennifer L.

Title: SVP and CFO

Shares: 4,864

Price/Share: $5.04

Value: $24,514.56

Shares Owned: 5,059

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-13	Hargroves, Thomas Jeffrey	Director	-	Indirect	Purchase	97,276	5.04	$490,271.04	97,468	4
2026-02-06	Brams, Matthew	Officer	EVP and Chief Medical Officer	Direct	Purchase	1,946	5.04	$9,807.84	4,656	4
2026-02-06	Werth, Peter J.	Director	-	Indirect	Purchase	19,455	5.04	$98,053.20	117,449	4
2026-02-06	Schaffer, Shane J.	Director,Officer	Chief Executive Officer	Indirect	Purchase	6,809	5.04	$34,317.36	10,175	4
2026-02-06	Callahan, Jennifer L.	Officer	SVP and CFO	Direct	Purchase	4,864	5.04	$24,514.56	5,059	4
2024-08-15	Myers, Laurie	Officer	EVP and COO	Direct	Sale	202	4.17	$842.34	0	4
2023-09-15	Callahan, Jennifer L.	Officer	Corporate Controller	Direct	Purchase	5,000	0.67	$3,350.00	45,508	4
2023-08-11	Werth, Peter J.	Director	-	Indirect	Purchase	1,823,155	0.55	$1,002,735.25	2,798,320	4
2023-05-15	Callahan, Jennifer L.	Officer	Corporate Controller	Direct	Purchase	2,000	1.01	$2,020.00	40,508	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

11.53%

Inst. Shares: 1,127,550

Shares Outstanding: 9,777,786

2025-12-31

10.15%

Inst. Shares: 513,326

Shares Outstanding: 5,055,329

2025-09-30

5.15%

Inst. Shares: 279,567

Shares Outstanding: 5,431,206

2025-06-30

3.56%

Inst. Shares: 156,476

Shares Outstanding: 4,389,465

2025-03-31

2.09%

Inst. Shares: 76,127

Shares Outstanding: 3,646,893

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,127,550	9,777,786	11.53%
2025-12-31	513,326	5,055,329	10.15%
2025-09-30	279,567	5,431,206	5.15%
2025-06-30	156,476	4,389,465	3.56%
2025-03-31	76,127	3,646,893	2.09%
2024-12-31	42,730	1,524,797	2.80%
2024-09-30	38,655	1,766,362	2.19%
2024-06-30	550,558	586,313	93.90%
2024-03-31	107,179	412,126	26.01%
2023-12-31	3,805	75,435	5.04%
2023-09-30	1,180,571	82,361	-
2023-06-30	398,260	974,179	40.88%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Cingulate Inc. (CING) — SEC Financial Statements & Analysis

Cingulate Inc. (CING) is a pharmaceutical preparations company, incorporated in DE. Cingulate Inc. trades on Nasdaq as: CING, CINGW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cingulate Inc. reported a Debt-to-Equity ratio of 0.41x, a Price-to-Book (P/B) ratio of 3.07x (TTM), at a market cap of $72.13M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.41x
P/B TTM: 3.07x
Market Cap: $72.13M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cingulate Inc. in?

Cingulate Inc. (CING) operates in the Pharmaceutical Preparations industry.

What is CING's market cap?

Cingulate Inc. (CING) has a market capitalization of $72.13M as of 2026-06-30.

What exchange does CING trade on?

Cingulate Inc. (CING) trades on the Nasdaq.

Where is Cingulate Inc. incorporated?

Cingulate Inc. is incorporated in DE.

Cingulate Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Cingulate Inc. (CING) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Cingulate Inc. (CING) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.